
How Antiviral Pill Molnupiravir Shot Ahead in the COVID Drug Hunt
The pharmaceutical firm Merck announced last week that an antiviral pill it’s developing can cut hospitalizations and deaths among people with COVID-19 by half. The results haven’t yet been peer reviewed. But if the drug candidate, molnupiravir, is authorized by … Continue reading How Antiviral Pill Molnupiravir Shot Ahead in the COVID Drug Hunt